Parallax Volatility Advisers
SIOX

Parallax Volatility Advisers’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Parallax Volatility Advisers’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,563
Closed -$66K – 4694
2017
Q4 		$66K Sell
1,563
-38,612
-96% -$1.73M ﹤0.01% 3058
2017
Q3 		$2.21M Buy
+40,175
New +$6.78M ﹤0.01% 818
2016
Q1 		– Sell
-8,938
Closed -$1.29M – 3965
2015
Q4 		$1.29M Buy
+8,938
New +$1.16M ﹤0.01% 1180

Other funds holding SIOX

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCA
Sassicaia Capital Advisers Jericho, New York $88.8M AUM 146.47% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return

Parallax Volatility Advisers's SIOX Position: Q4 2020 in Review

Parallax Volatility Advisers sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q4 2020, closing a stake of 6,818 shares — an estimated $31K sold.

Parallax Volatility Advisers first reported a position in SIOX in Q4 2015 and held it in 4 quarters. The position peaked at $633K in Q3 2017. 62 funds tracked by Wall St. Rank hold SIOX as of Q4 2020.

  • Parallax Volatility Advisers reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Parallax Volatility Advisers sold 6,818 Sio Gene Therapies Inc. Common Stock shares in Q4 2020, an estimated $31K.
  • Parallax Volatility Advisers first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2015 and held it in 4 quarters.
  • Parallax Volatility Advisers's Sio Gene Therapies Inc. Common Stock position peaked at $633K in Q3 2017.
  • 62 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q4 2020.

Based on Parallax Volatility Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.